Lazard Asset Management’s Editas Medicine EDIT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-76
| Closed | – | – | 2369 |
|
|
2024
Q4 | $0 | Hold |
76
| – | – | ﹤0.01% | 2346 |
|
|
2024
Q3 | $0 | Sell |
76
-128
| -63% | – | ﹤0.01% | 2311 |
|
|
2024
Q2 | $0 | Sell |
204
-2,870
| -93% | – | ﹤0.01% | 2287 |
|
|
2024
Q1 | $22K | Sell |
3,074
-1,706
| -36% | -$12.2K | ﹤0.01% | 1829 |
|
|
2023
Q4 | $47K | Buy |
4,780
+185
| +4% | +$1.82K | ﹤0.01% | 1901 |
|
|
2023
Q3 | $35K | Buy |
4,595
+2,062
| +81% | +$15.7K | ﹤0.01% | 1952 |
|
|
2023
Q2 | $20K | Sell |
2,533
-54
| -2% | -$426 | ﹤0.01% | 2095 |
|
|
2023
Q1 | $18K | Sell |
2,587
-2,897
| -53% | -$20.2K | ﹤0.01% | 2068 |
|
|
2022
Q4 | $47K | Sell |
5,484
-4,068
| -43% | -$34.9K | ﹤0.01% | 1846 |
|
|
2022
Q3 | $116K | Buy |
9,552
+873
| +10% | +$10.6K | ﹤0.01% | 1415 |
|
|
2022
Q2 | $102K | Sell |
8,679
-116,226
| -93% | -$1.37M | ﹤0.01% | 1497 |
|
|
2022
Q1 | $2.38M | Buy |
124,905
+34,249
| +38% | +$651K | ﹤0.01% | 871 |
|
|
2021
Q4 | $2.41M | Buy |
90,656
+46,587
| +106% | +$1.24M | ﹤0.01% | 902 |
|
|
2021
Q3 | $1.81M | Buy |
44,069
+2,074
| +5% | +$85.2K | ﹤0.01% | 928 |
|
|
2021
Q2 | $2.38M | Buy |
41,995
+41,345
| +6,361% | +$2.34M | ﹤0.01% | 828 |
|
|
2021
Q1 | $27K | Sell |
650
-2,451
| -79% | -$102K | ﹤0.01% | 1679 |
|
|
2020
Q4 | $217K | Buy |
+3,101
| New | +$217K | ﹤0.01% | 1090 |
|
|
2020
Q3 | – | Sell |
-79
| Closed | -$2K | – | 1638 |
|
|
2020
Q2 | $2K | Buy |
+79
| New | +$2K | ﹤0.01% | 1557 |
|